Same-day Radioembolization for Large HCC
ConditionHepatocellular Carcinoma (HCC)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorSeoul National University Hospital
About this trial
In patients who has no sign suggesting high lung shunt fraction (TIPS, hepatic vein invasion, hepatic vein enhancement on arterial phase, dysmorphic intratumoral vessel), planning angiography, MAA scan, and radioembolization are performed in a single day with SIR-Spheres. This prospective registry will prove that the selection criteria is accurate and same-day radioembolization is feasible and safe.
Eligibility criteria
Qualifiers
Patients diagnosed with hepatocellular carcinoma histologically and/or radiologically (LI-RADS 4 or 5)
hepatocellular carcinoma 5cm or larger
dysmorphic intratumoral vessels 3mm or smaller
Child-Pugh class A
Disqualifiers
hepatic vein invasion on CT/MRI
Marked enhancement of portal vein or hepatic vein on arterial phase of CT/MRII
TIPS
dysmorphic intratumoral vessels > 3mm
Trial design
Treatments tested in this trial
- same-day radioembolization
Treatment groups
138 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov